Mechanisms of VEGF (Vascular Endothelial Growth Factor) Inhibitor-Associated Hypertension and Vascular Disease.
作者信息
Pandey Arvind K, Singhi Eric K, Arroyo Juan Pablo, Ikizler Talat Alp, Gould Edward R, Brown Jonathan, Beckman Joshua A, Harrison David G, Moslehi Javid
机构信息
From the Division of Cardiovascular Medicine (A.K.P., E.K.S., J.B., J.A.B., J.M.), Division of Nephrology (J.P.A., T.A.I., E.R.G.), Vanderbilt Center for Kidney Disease (T.A.I.), Division of Clinical Pharmacology (D.G.H.) and Cardio-Oncology Program (J.M.), Department of Medicine, Vanderbilt University Medical Center, Nashville, TN.
出版信息
Hypertension. 2018 Feb;71(2):e1-e8. doi: 10.1161/HYPERTENSIONAHA.117.10271. Epub 2017 Dec 26.
Abstract
摘要
相似文献
1
Mechanisms of VEGF (Vascular Endothelial Growth Factor) Inhibitor-Associated Hypertension and Vascular Disease.
Hypertension. 2018 Feb;71(2):e1-e8. doi: 10.1161/HYPERTENSIONAHA.117.10271. Epub 2017 Dec 26.
2
Vascular endothelial growth factor inhibitor-induced hypertension: from pathophysiology to prevention and treatment based on long-acting nitric oxide donors.
Am J Hypertens. 2014 Jan;27(1):3-13. doi: 10.1093/ajh/hpt201. Epub 2013 Oct 29.
3
Cardiovascular and renal toxicity during angiogenesis inhibition: clinical and mechanistic aspects.
J Hypertens. 2009 Dec;27(12):2297-309. doi: 10.1097/HJH.0b013e3283309b59.
4
Noncardiac vascular toxicities of vascular endothelial growth factor inhibitors in advanced cancer: a review.
Oncologist. 2011;16(4):432-44. doi: 10.1634/theoncologist.2010-0271. Epub 2011 Mar 25.
5
Anti-VEGF Anticancer Drugs: Mind the Hypertension.
Recent Adv Cardiovasc Drug Discov. 2014;9(2):63-72. doi: 10.2174/1574890110999150604114127.
6
Proteinuria and hypertension in patients treated with inhibitors of the VEGF signalling pathway--incidence, mechanisms and management.
Folia Biol (Praha). 2013;59(1):15-25.
7
Use of Antihypertensive Drugs in Neoplastic Patients.
High Blood Press Cardiovasc Prev. 2017 Jun;24(2):127-132. doi: 10.1007/s40292-017-0198-z. Epub 2017 Mar 30.
8
Hypertension and proteinuria: a class-effect of antiangiogenic therapies.
Anticancer Drugs. 2009 Jan;20(1):81-2. doi: 10.1097/CAD.0b013e3283161012.
9
Hypertension as a surrogate marker for the activity of anti-VEGF agents.
Ann Oncol. 2009 May;20(5):967-70. doi: 10.1093/annonc/mdp206.
10
Renal toxicity of anticancer agents targeting vascular endothelial growth factor (VEGF) and its receptors (VEGFRs).
J Nephrol. 2017 Apr;30(2):171-180. doi: 10.1007/s40620-016-0311-8. Epub 2016 May 6.
引用本文的文献
1
Tyrosine kinase inhibitors - balancing the haemostatic scales: a review of associated thrombosis and bleeding.
J Thromb Thrombolysis. 2025 Sep 15. doi: 10.1007/s11239-025-03151-w.
2
Exploring the genetic alterations of Gorham-Stout disease.
Front Endocrinol (Lausanne). 2025 Aug 19;16:1654497. doi: 10.3389/fendo.2025.1654497. eCollection 2025.
3
Non-Obstructive Azoospermia: Influence of PRP on Proliferation, Apoptosis, and Growth Factors of Male Germ Cells.
Medicina (Kaunas). 2025 Aug 12;61(8):1450. doi: 10.3390/medicina61081450.
4
VEGFR1 as a Target for Cardiovascular Gene Therapy.
J Cardiovasc Transl Res. 2025 Aug 21. doi: 10.1007/s12265-025-10672-5.
5
Bevacizumab-associated glomerular microangiopathy: a case report and literature review.
BMC Nephrol. 2025 Aug 9;26(1):445. doi: 10.1186/s12882-025-04385-9.
6
Adverse Event Management in Patients with Platinum-Resistant Ovarian Cancer Treated with Niraparib and Anlotinib: Updates from the Phase II, Multi-Center ANNIE Study.
Ther Clin Risk Manag. 2025 Jul 21;21:1135-1147. doi: 10.2147/TCRM.S526755. eCollection 2025.
7
Co-occurrence of endometriosis with psoriasis and psoriatic arthritis: Genetic insights (Review).
Exp Ther Med. 2025 Jul 10;30(3):171. doi: 10.3892/etm.2025.12921. eCollection 2025 Sep.
8
Dissecting the relationship between heart failure and diabetic retinopathy severity in patients with diabetes and chronic kidney disease: an observational cohort study.
Sci Rep. 2025 Jul 8;15(1):24346. doi: 10.1038/s41598-025-04523-1.
9
Angiotensin Receptor Neprilysin Inhibitors for Hypertension and Proteinuria Management During Atezolizumab/Bevacizumab Treatment for Hepatocellular Carcinoma.
Cancer Diagn Progn. 2025 Jun 30;5(4):485-491. doi: 10.21873/cdp.10462. eCollection 2025 Jul-Aug.
10
Navigating the Complexities of Cancer Treatment-Induced Hypertension.
J Cardiovasc Dev Dis. 2025 Jun 19;12(6):235. doi: 10.3390/jcdd12060235.
本文引用的文献
1
Recent Advances in Hypertension and Cardiovascular Toxicities With Vascular Endothelial Growth Factor Inhibition.
Hypertension. 2017 Aug;70(2):220-226. doi: 10.1161/HYPERTENSIONAHA.117.08856. Epub 2017 Jun 19.
2
Salt Sensitivity of Angiogenesis Inhibition-Induced Blood Pressure Rise: Role of Interstitial Sodium Accumulation?
Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20.
3
Cardiovascular Toxic Effects of Targeted Cancer Therapies.
N Engl J Med. 2016 Oct 13;375(15):1457-1467. doi: 10.1056/NEJMra1100265.
4
Risk factors of proteinuria in renal cell carcinoma patients treated with VEGF inhibitors: a secondary analysis of pooled clinical trial data.
Br J Cancer. 2016 Jun 14;114(12):1313-7. doi: 10.1038/bjc.2016.147. Epub 2016 May 26.
5
Endothelial fluid shear stress sensing in vascular health and disease.
J Clin Invest. 2016 Mar 1;126(3):821-8. doi: 10.1172/JCI83083.
6
Ten years of anti-vascular endothelial growth factor therapy.
Nat Rev Drug Discov. 2016 Jun;15(6):385-403. doi: 10.1038/nrd.2015.17. Epub 2016 Jan 18.
7
Vascular and Metabolic Implications of Novel Targeted Cancer Therapies: Focus on Kinase Inhibitors.
J Am Coll Cardiol. 2015 Sep 8;66(10):1160-78. doi: 10.1016/j.jacc.2015.07.025.
8
Endothelin-1 as a master regulator of whole-body Na+ homeostasis.
FASEB J. 2015 Dec;29(12):4937-44. doi: 10.1096/fj.15-276584. Epub 2015 Aug 12.
9
Greater Sensitivity of Blood Pressure Than Renal Toxicity to Tyrosine Kinase Receptor Inhibition With Sunitinib.
Hypertension. 2015 Sep;66(3):543-9. doi: 10.1161/HYPERTENSIONAHA.115.05435. Epub 2015 Jul 20.
10
Intramembrane binding of VE-cadherin to VEGFR2 and VEGFR3 assembles the endothelial mechanosensory complex.
J Cell Biol. 2015 Mar 30;208(7):975-86. doi: 10.1083/jcb.201408103. Epub 2015 Mar 23.
Zotero 插件